Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Compound Danshen Tablets (Fufang Danshen Pian) is a traditional Chinese herbal formulation developed and manufactured by Beijing Tong Ren Tang. It is composed of three primary herbal ingredients: Danshen (*Salvia miltiorrhiza*), Sanqi (*Panax notoginseng*), and Borneol (*Bingpian*). This oral formulation is traditionally used to promote blood circulation, remove blood stasis, regulate qi, and alleviate pain. Its primary clinical indications include the relief of chest tightness and the support of cardiovascular health, particularly in conditions associated with coronary heart disease. As a traditional herbal compound, it functions through the synergistic effects of its botanical constituents according to Traditional Chinese Medicine (TCM) principles rather than a single defined molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Compound Danshen Tablets.